Multiple myeloma (MM) is characterized by copy number abnormalities (CNAs), some of which influence patient outcomes and are sometimes observed only...

Therefore, systemic study on IgD MM is purposeful to disclose the recurrent and refractory features in both IgD and other types of MM, and beneficial...

Extensive genetic and transcriptional characterization of myeloma has identified subtypes with prognostic and therapeutic implications. In contrast...

Despite the improvement of therapeutic regimens, several patients with multiple myeloma (MM) still experience early relapse (ER). This subset of...

On the basis of simple, widely available baseline features, the S-ERMM and DS-ERMM properly identified patients with different risks of ER and...

The LR classifier performed better than the other classifiers based on different data (AUC: 0.65-0.82; P < 0.05)

We retrospectively reviewed and compared the clinical features and outcomes in 226 MM patients with or without EMD at their diagnosis

Our study demonstrates that pre-existing hypertension was significantly associated with a lower PFS in newly diagnosed MM patients

The magnitude of OS benefit with upfront HDT is cytogenetics-dependent. Patients with high-risk cytogenetics should preferably receive upfront rather...

This is likely attributable to underlying disease biology and prevention of end-organ damage by early treatment initiation, as benefit was independent...